Literature DB >> 22384797

Neonatal cyanosis due to a new (G)γ-globin variant causing low oxygen affinity: Hb F-Sarajevo [(G)γ102(G4)Asn→Thr, AAC>ACC].

Urs Zimmermann-Baer1, Ralph Capalo, Fabrizio Dutly, Elisabeth Saller, Heinz Troxler, Malcolm Kohler, Hannes Frischknecht.   

Abstract

A baby girl, born at term, presented with severe cyanosis and received oxygen supplementation. Consecutive arterial blood gas analysis showed a pronounced right shift of the saturation curve, suggesting the presence of a hemoglobin (Hb) variant. A new (G)γ-globin variant was detected, namely HBG2:c.308G, which we have named Hb F-Sarajevo, the city from where the baby's parents originate. This A to C transversion exists in cis to the common (A)γ(T) and the resulting mutant Hb molecule exhibits very low oxygen affinity and cooperativity. Its analogue in the β-globin gene is Hb Kansas [β102(G4)AsnThr, AAC>ACC].

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22384797     DOI: 10.3109/03630269.2012.655872

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  Beth-Israel Hemoglobin: An Uncommon Cause of Cyanosis in a 9-year-old Boy.

Authors:  Lakshmi Madhumathi Marimuthu; C G Delhi Kumar
Journal:  Indian J Pediatr       Date:  2018-03-21       Impact factor: 1.967

2.  Diagnosis of a rare fetal haemoglobinopathy in the age of next-generation sequencing.

Authors:  Thomas A Hooven; Ellen M Hooper; Sandeep N Wontakal; Richard O Francis; Rakesh Sahni; Margaret T Lee
Journal:  BMJ Case Rep       Date:  2016-04-19

3.  First Observation of Hemoglobin Kansas [β102(G4)Asn→Thr, AAC>ACC] in the Turkish Population.

Authors:  İbrahim Keser; Alev Öztaş; Türker Bilgen; Duran Canatan
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

4.  The Second and Third Hemoglobin Kansas Cases in the Turkish Population.

Authors:  Zeynep Kayra Tanrıverdi; Arzu Akyay; Aşkın Şen; Çağatay Taşkapan; Ünsal Özgen
Journal:  Turk J Haematol       Date:  2017-01-02       Impact factor: 1.831

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.